Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1996 | 09-1996 | 06-1996 | 03-1996 | 12-1995 | |
| Sales | 3,955,000 | 3,745,000 | 3,696,000 | 3,669,000 | 3,608,000 |
| Cost of Goods | 1,065,000 | 1,003,000 | 962,000 | 935,000 | 921,000 |
| Gross Profit | 2,890,000 | 2,742,000 | 2,734,000 | 2,734,000 | 2,687,000 |
| Operating Expenses | 1,942,000 | 1,682,000 | 1,811,000 | 1,712,000 | 1,824,000 |
| Operating Income | 948,000 | 1,060,000 | 923,000 | 1,022,000 | 863,000 |
| Interest Expense | 0 | 0 | 0 | 0 | -275,000 |
| Other Income | 60,000 | 0 | 0 | 0 | -1,213,000 |
| Pre-tax Income | 1,008,000 | 1,060,000 | 923,000 | 1,022,000 | -75,000 |
| Income Tax | 292,000 | 307,000 | 268,000 | 296,000 | 67,000 |
| Net Income Continuous | 716,000 | 753,000 | 655,000 | 726,000 | -142,000 |
| Net Income | $716,000 | $753,000 | $655,000 | $726,000 | $-142,000 |
| EPS Basic Total Ops | 0.36 | 0.38 | 0.33 | 0.36 | -0.07 |
| EPS Basic Continuous Ops | 0.36 | 0.38 | 0.33 | 0.36 | -0.07 |
| EPS Diluted Total Ops | 0.36 | 0.38 | 0.33 | 0.36 | -0.07 |
| EPS Diluted Continuous Ops | 0.36 | 0.38 | 0.33 | 0.36 | -0.07 |
| EBITDA(a) | $1,087,000 | $1,186,000 | $1,046,000 | $1,153,000 | $863,000 |